Mirae Asset Global Etfs Holdings Ltd. Neuronetics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Neuronetics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 19,760 shares of STIM stock, worth $55,920. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,760Holding current value
$55,920% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding STIM
# of Institutions
98Shares Held
18.6MCall Options Held
49.6KPut Options Held
78.8K-
Vanguard Group Inc Valley Forge, PA2.74MShares$7.76 Million0.0% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.74MShares$4.92 Million1.44% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.51MShares$4.27 Million0.01% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.1MShares$3.11 Million1.17% of portfolio
-
Masters Capital Management LLC Atlanta, GA1MShares$2.83 Million0.14% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $76.5M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...